Skip to main content

Table 1 Participant profile

From: Intravenous and oral whole body ketone dosimetry, biodistribution, metabolite correction and kinetics studied by (R)-[1-11C]β-hydroxybutyrate ([11C]OHB) PET in healthy humans

Age (years)

56.3 \(\pm \hspace{0.17em}\)5.4

BMI (kg/m2)

27.7 \(\pm \hspace{0.17em}\)2,6

Systolic blood pressure

132.8 \(\pm \hspace{0.17em}\)8.4

Diastolic blood pressure (mmHg)

85.7 \(\pm \hspace{0.17em}\)6.7

Cholesterol (mmol/L)

4.8 \(\pm \hspace{0.17em}\)0.3

HDL (mmol/L)

1.5 \(\pm \hspace{0.17em}\)0.3

LDL (mmol/L)

2.6 \(\pm \hspace{0.17em}\)0.4

Triglyceride (mmol/L)

1.5 \(\pm \hspace{0.17em}\)0.7

HbA1c (mmol/mol)

34.7 \(\pm \hspace{0.17em}\)6.1

Glucose (mmol/L)

5.9 \(\pm \hspace{0.17em}\)0.9

Alanine transaminase (U/L)

25.5 \(\pm \hspace{0.17em}\)10.0

Alkaline phosphatase (U/L)

68.31 \(\pm \hspace{0.17em}\)2.7

Hemoglobin (mmol/L)

8.3 \(\pm \hspace{0.17em}\)1.0

  1. Values are mean \(\pm\) SD